Researchers edge closer to delivering personalized medicine to cancer patients

FEBRUARY 14, 2024byPurdue UniversityDr. Michael Childress (right), Professor of Comparative Oncology at the Purdue University College of Veterinary Medicine, is pictured with Kody (middle) and h

Updated on: March 28,2024 2

Researchers edge closer to delivering personalized medicine to cancer patients

FEBRUARY 14, 2024byPurdue UniversityDr. Michael Childress (right), Professor of Comparative Oncology at the Purdue University College of Veterinary Medicine, is pictured with Kody (middle) and h

Updated on:March 28,2024 2

A naturally-occurring molecule shows promise as effective first-line treatment for prostate cancer

JANUARY 5, 2024byNottingham Trent UniversityLive-cell cytotoxicity analysis shows that carnosine induces the death of PC346Flu1 (A) and TRAMP-C1 (B) cells. Carnosine inhibited cell growth in a d

Updated on: March 28,2024 3

A naturally-occurring molecule shows promise as effective first-line treatment for prostate cancer

JANUARY 5, 2024byNottingham Trent UniversityLive-cell cytotoxicity analysis shows that carnosine induces the death of PC346Flu1 (A) and TRAMP-C1 (B) cells. Carnosine inhibited cell growth in a d

Updated on:March 28,2024 3

Researchers find Boswellia, an extract of frankincense, shows anti-cancer activity in small trial

JANUARY 11, 2024by Leslie Cantu,Medical University of South CarolinaMajor types of boswellic acids in B. serrate. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s105

Updated on: March 28,2024 5

Researchers find Boswellia, an extract of frankincense, shows anti-cancer activity in small trial

JANUARY 11, 2024by Leslie Cantu,Medical University of South CarolinaMajor types of boswellic acids in B. serrate. Credit:Breast Cancer Research and Treatment(2024). DOI: 10.1007/s105

Updated on:March 28,2024 5

Researchers show xCT protein is key link in inhibiting pancreatic cancer growth and limiting mood disturbances

by Vrije Universiteit BrusselCredit: Pixabay/CC0 Public DomainThe xCT protein, which plays an important role as a transport molecule in cells, could play a part in cancer treatment in the future, rese

Updated on: March 28,2024 0

Researchers show xCT protein is key link in inhibiting pancreatic cancer growth and limiting mood disturbances

by Vrije Universiteit BrusselCredit: Pixabay/CC0 Public DomainThe xCT protein, which plays an important role as a transport molecule in cells, could play a part in cancer treatment in the future, rese

Updated on:March 28,2024 0

Research uncovers how to target 'sleeping' breast cancer cells and prevent relapse

byInstitute of Cancer ResearchModel: Endocrine therapy-induced dormancy is characterized by a consistent epigenetic reprogramming involving a global increase in histone repressive marks. The dor

Updated on: March 28,2024 0

Research uncovers how to target 'sleeping' breast cancer cells and prevent relapse

byInstitute of Cancer ResearchModel: Endocrine therapy-induced dormancy is characterized by a consistent epigenetic reprogramming involving a global increase in histone repressive marks. The dor

Updated on:March 28,2024 0

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

FEBRUARY 15, 2024byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainAn innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but

Updated on: March 29,2024 3

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

FEBRUARY 15, 2024byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainAn innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but

Updated on:March 29,2024 3

Oncology trial shows positive results for patients with muscle-invasive urothelial carcinoma

JANUARY 26, 2024by Alliance for Clinical Trials in OncologyCredit: Pixabay/CC0 Public DomainPatients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new t

Updated on: March 30,2024 5

Oncology trial shows positive results for patients with muscle-invasive urothelial carcinoma

JANUARY 26, 2024by Alliance for Clinical Trials in OncologyCredit: Pixabay/CC0 Public DomainPatients with muscle-invasive urothelial cancer and a high risk of recurrence after surgery may have a new t

Updated on:March 30,2024 5

Avoid food poisoning this holiday season

by Dennis Thompson and Carole Tanzer Miller sThe last thing a holiday host wants is to have guests get food poisoning from the feast they've set.That's whyfood safetyis particularl

Updated on: March 30,2024 18

Avoid food poisoning this holiday season

by Dennis Thompson and Carole Tanzer Miller sThe last thing a holiday host wants is to have guests get food poisoning from the feast they've set.That's whyfood safetyis particularl

Updated on:March 30,2024 18

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on: March 30,2024 19

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on:March 30,2024 19

Multiple myeloma survival down with high ADAR1 RNA expression

(HealthDay)—Amplification of the inflammation-responsive RNA editase adenosine deaminase acting on RNA (ADAR)1 gene is associated with reduced survival in multiple myeloma (MM), according to a study p

Updated on: March 30,2024 14

Multiple myeloma survival down with high ADAR1 RNA expression

(HealthDay)—Amplification of the inflammation-responsive RNA editase adenosine deaminase acting on RNA (ADAR)1 gene is associated with reduced survival in multiple myeloma (MM), according to a study p

Updated on:March 30,2024 14

AI model uses serial imaging to predict lung cancer therapy response

(HealthDay)—For patients with locally advanced non-small cell lung cancer (NSCLC), deep-learning networks integrating computed tomography (CT) scans at multiple time points can improve clinical outcom

Updated on: March 30,2024 17

AI model uses serial imaging to predict lung cancer therapy response

(HealthDay)—For patients with locally advanced non-small cell lung cancer (NSCLC), deep-learning networks integrating computed tomography (CT) scans at multiple time points can improve clinical outcom

Updated on:March 30,2024 17

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on: March 30,2024 15

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on:March 30,2024 15